Spontaneous laceration of spleen with hilar lymph node metastasis: a case of primary splenic mantle cell lymphoma in elderly

Authors

  • Mithlesh Bhargav Department of Pathology and Lab Medicine, AIIMS Gorakhpur, Uttar Pradesh, India
  • Bandana Mehrotra Lab director, RML Labs Lucknow, Uttar Pradesh, India
  • Ashok Kapoor Department of Histopathology, RML Labs Lucknow, Uttar Pradesh, India
  • Vaibhav Raj Gopal Department of General Surgery, RMLIMS, Lucknow, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20241268

Keywords:

Malignant neoplasm, Lymphoma, Spleen, Hilar lymph nodes

Abstract

Mantle cell lymphoma (MCL) is a type of non-Hodgkin (B-cell) lymphoma (NHL) with manifestations ranging from indolent to aggressive disease. It arises from mantle zone or primary follicle lymphocytes and is associated with translocation t (11;14) which is seen in almost all cases. Most of the cases present at stage III/IV with hepatospenomegaly, generalized lymphadenopathy, bone marrow involvement or lymphoid polyposis. Rate of relapse is high occurring in 50-60% patients and 5-year survival rates are low ~27-30%. Median overall survival is 3.5 years. Age >60 years, raised serum LDH, high mitotic count, Ki67>30%, blastoid or pleomorphic variants, TP53 mutation, gains in 3q,11q and deletions of 13q as well as 17p are important prognostic factors associated with worst outcome. Treatment involves conventional chemo-immunotherapy and stem cell transplantation (SCT). In our case the elderly patient had an atraumatic splenic rupture with no past medical history of trauma. The patient presented to the emergency department with severe abdominal pain in left upper quadrant. Thus emergency splenectomy was executed successfully, and the patient was stabilized. After receiving initial cycle of R-CHOP regime, he was lost to follow up. In this case report, we will discuss the clinical presentation, as well as current treatment guidelines for atraumatic splenic rupture.

Metrics

Metrics Loading ...

References

Iannitti E, Tripodo C. How I diagnose and treat splenic lymphomas. Blood. 2011;117(9):2585-95.

Plummer PD, Yglesias B, Swiger A, Mashburn P. Mantle Cell Lymphoma With Non-traumatic Splenic Rupture Requiring Emergency Splenectomy. Cureus. 2022;14(5):24675.

Vose JM. Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management. Am J Hematol. 2017;92:806–13.

Li S, Xu J, You MJ. The pathologic diagnosis of mantle cell lymphoma. Histol Histopathol. 2021;36:1037–51.

Sander B, Quintanilla-Martinez L, Ott G. Mantle cell lymphoma--a spectrum from indolent to aggressive disease. Virchows Arch. 2016;468:245–57.

Qie S, Diehl JA. Cyclin D1, cancer progression, and opportunities in cancer treatment. J Mol Med (Berl) 2016;94:1313–26.

Ye H, Desai A, Zeng D, Romaguera J, Wang ML. Frontline treatment for older patients with mantle cell lymphoma. Oncologist. 2018;23:1337–48.

Eyerer F, Gardner JA, Devitt KA. Mantle cell lymphoma presenting with lethal atraumatic splenic rupture. Autops Case Rep. 2021;11:0.

Tan CB, Rajan D, Majeed S, Ahmed S, Freedman L, Mustacchia P. Pathologic rupture of the spleen in mantle-cell-type non-Hodgkin's lymphoma. Case Rep Med. 2012;2012:351275.

Downloads

Published

2024-04-30

How to Cite

Bhargav, M., Mehrotra, B., Kapoor, A., & Raj Gopal, V. (2024). Spontaneous laceration of spleen with hilar lymph node metastasis: a case of primary splenic mantle cell lymphoma in elderly. International Journal of Research in Medical Sciences, 12(5), 1738–1741. https://doi.org/10.18203/2320-6012.ijrms20241268

Issue

Section

Case Reports